Open original FDA record ↗Recall record
- FDA identifier
- Z-1932-2011
- Company in FDA record
- Bio-Rad Laboratories Inc
- FDA classification date
- Apr 11, 2011
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Some customers have reported the occurrence of some ramping baselines on the chromatograms. The ramping baseline can affect hemoglobin test results.
Source facts
- Action
- Bio Rad Laboratories, Inc. sent an Urgent Medical Device Correction letter dated December 1, 2009, to all affected customers. The letter identified the product, the problem, and the action to be taken by the customer. Customers were instructed to immediatey examine their records to identify all customers who received one of the affected lots. Collect a Customer Medical Device Correction Response Form from every customer. Once forms were received from all applicable customers, complete the following Medical Device Correction Response Form and fax it to Bio-Rad CSD Regulatory Affairs at 510-741-3954 or pdf to CSD Recall Coordinator (excluding USSD). For questions regarding this recall call 510-724-7000.
- Initiated
- 2009-12-01
- Root cause
- Software change control
- Terminated
- 2011-08-30
- Distribution
- Worldwide Distribution - USA (nationwide) and the countries of Australia, New Zealand, Taiwan, Singapore, India, China, S. Korea, Hong Kong, France, Sweden, United Kingdom, Italy, Hungary, Germany, Brazil, Mexico and Colombia.
- Recall number
- Z-1932-2011
- Recall status
- Terminated
- CDRH record ID
- 88565
- FDA classified
- 2011-04-11
- Recall event number
- 54483